Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Covidien Announces Health Canada Approval For Its Generic Myocardial Perfusion Imaging Kit
Covidien (NYSE: COV), a leading global provider of healthcare products, announced that Health Canada has approved the Company"s Abbreviated New Drug Submission (ANDS) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien"s generic product is fully substitutable for Cardiolite®, a myocardial perfusion imaging agent used for detecting coronary artery disease.
generic viagra online
Purdue-developed Tool Can Get Most Pollution Control For The Money
There may be thousands of things large and small that can be done to better control pollution on even the smallest waterways, and a new tool developed at Purdue University may help sort out how to choose the best ones.
News of the day
Low-Dose CT Method, Delivering 50% Less Radiation, Correctly Identifies Patients With Appendicitis
Patients with possible appendicitis are typically evaluated using a standard-dose contrast enhanced CT, but a low-dose unenhanced CT that delivers approximately 50% less radiation is just as effective, according to a study performed at the Seoul National University College of Medicine in Seoul, Korea. The standard-dose enhanced CT scan delivers approximately 8.0 mSv of radiation; the low-dose unenhanced CT scan delivers approximately 4.2 mSv of radiation.
Health Insurance

Covidien Announces Health Canada Approval For Its Generic Myocardial Perfusion Imaging Kit

Covidien (NYSE: COV), a leading global provider of healthcare products, announced that Health Canada has approved the Company"s Abbreviated New Drug Submission (ANDS) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien"s generic product is fully substitutable for Cardiolite®, a myocardial perfusion imaging agent used for detecting coronary artery disease. With Health Canada approval of the ANDS, which was filed by the Company"s Canadian subsidiary, Covidien"s generic product is expected to be available for customers in Canada this summer. The Company"s generic product also is available in the U.S., the U.K., Denmark, Germany and Puerto Rico. "We are pleased to receive approval in Canada and to introduce this generic diagnostic option to meet patients" needs," said Timothy R. Wright, President, Pharmaceutical Products and Imaging Solutions, Covidien. Covidien"s Imaging Solutions business is a leading provider of radiopharmaceuticals used in nuclear medicine imaging procedures. It also supplies contrast media delivery systems, which combine contrast media and power injectors, for Computed Tomography (CT), X-ray and Magnetic Resonance Imaging (MRI) procedures. Covidien


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009